Last10K.com

Annexon, Inc. (ANNX) SEC Filing 8-K Material Event for the period ending Thursday, February 25, 2021

Annexon, Inc.

HISTORY TOOLS
CIK: 1528115 Ticker: ANNX

View differences made from one to another to evaluate Annexon, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Annexon, Inc..

Continue

Assess how Annexon, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Annexon, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: ANNX
CIK: 1528115
Form Type: 8-K Corporate News
Accession Number: 0001193125-21-063399
Submitted to the SEC: Mon Mar 01 2021 4:05:58 PM EST
Accepted by the SEC: Mon Mar 01 2021
Period: Thursday, February 25, 2021
Industry: Pharmaceutical Preparations
Events:
  1. Event for Officers

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/annx/0001193125-21-063399.htm